Favorable MMPI-2 Changes After 3 Months of Initiating Testosterone Treatment in FTMs: A Prospective Controlled Study Part 1 of 2

submitted by: ColtMeier

The graduate student symposium showcases the latest research in transgender health from graduate students, post-doctoral fellows, and other advanced research trainees across a variety of academic disciplines.

Health Behaviors and Perceived Healthcare Needs of Trans Masculine Adults: Findings From a Mixed Methods Community-Based Needs Assessment: Part 2 of 2

submitted by: ColtMeier

The graduate student symposium showcases the latest research in transgender health from graduate students, post-doctoral fellows, and other advanced research trainees across a variety of academic disciplines.

De geschiedenis van de Pathologie, een reis door de archieven

submitted by: LUMC_PA_MD
Technologische vooruitgang in de pathologie. Een reis door de archieven. Van anatomisch theater naar “gepersonaliseerde geneeskunde”. Deze video presentatie is gemaakt ten behoeve van de promotie van Ronald van Eijk d.d. 8 mei 2013 op het proefschrift: Technological Advances in Molecular Pathology. A journey into the Archives De presentatie geeft een populair wetenschappelijk beeld van de ontwikkelingen in de Pathologie. In de loop der eeuwen zijn er vele revolutionaire, breed...

Stereotactic body radiation therapy (SBRT) for lung cancer

submitted by: mdanderson
Stereotactic body radiation therapy (SBRT), also called stereotactic ablative radiotherapy (SABR), is a type of radiation therapy in which a few very high doses of radiation are delivered to small, well-defined tumors. The goal is to deliver a radiation dose that is high enough to kill the cancer while minimizing exposure to surrounding healthy organs. Barbara Pool is one of six lung cancer patients per day who go through stereotactic body radiation therapy and she is the 1000th patient to...

Safety of Clopidogrel in Hip Fracture Surgery

submitted by: WentzMR
Dr. Molly Feely, a consultant in the Division of General Internal Medicine at Mayo Clinic in Rochester, MN, discusses her article appearing in the February 2013 issue of Mayo Clinic Proceedings, where no Perioperative complications were found when comparing outcomes between patients with hip fractures using and not using Clopidogrel. The Rochester Epidemiology Project provided the patient data. Available at: http://tinyurl.com/b45osdu

Stratifying Risk of Urinary Tract Malignant Tumors in Patients With Asymptomatic Microscopic Hematuria

submitted by: WentzMR

Dr. Ronald Loo, Regional Chief of Urology at Southern California Permanente Medical Group in Pasadena, CA, shares results of a prospective study appearing in the February 2013 issue of Mayo Clinic Proceedings on the detection of the risk for bladder cancer based on levels of blood found in the urine. Available at: http://tiny.cc/fplcqw